【ChiCTR1800016588】Mindfulness based intervention for Chinese children with autism and their parents: a randomised controlled trial
ChiCTR1800016588
正在进行
/
/
/
2018-06-11
/
/
孤獨症譜系障礙
Mindfulness based intervention for Chinese children with autism and their parents: a randomised controlled trial
Mindfulness based intervention for Chinese children with autism and their parents: a randomised controlled trial
The objective of this randomized controlled trial is to examine the effectiveness of a mindfulness-based intervention specifically developed for children with ASD aged 8 to 18 years on their well-being, autism-related symptoms, behaviours, resilience, family relationship, mindfulness level and health service utilization, as well as their parents parental stress, well being, rumination, and health service utilization in Hong Kong, comparing to waiting list control.
随机平行对照
治疗新技术
The randomisation will be conducted by an experienced independent statistician using computer-generated random results.
Participants will be informed of their group assignments. The research staff member who conducts the assessments or the statistical analysis will be kept blinded of the group assignment.
The D. H. Chen Foundation, Hong Kong SAR
/
140
/
2018-06-28
2021-06-27
/
Participants will include both children with ASD and their parents. The inclusion criteria will be (1) children aged 8-18 years who have been previously diagnosed with ASD by a doctor according to the Diagnostic and Statistical Manual of Mental Disorders-4/5 (DSM-4/5) diagnostic criteria; (2) and at least one of their parents agrees to participate.；
请登录查看The exclusion criteria will be: (1) being unable to communicate and understand Chinese language as the intervention will be conducted in Chinese; (2) having a medical condition rendering him/her to be incapable to participate in the study; (3) unwilling or unable to give consent.；
请登录查看The D. H. Chen Foundation, Hong Kong SAR
/
The D. H. Chen Foundation, Hong Kong SAR的其他临床试验
- Mindfulness-based intervention for children/youth with internalizing problems and their families: a pilot study
- Mindfulness based intervention for Chinese children with autism and their parents: a randomised controlled trial
- A randomised controlled trial comparing MYmind with waitlist control among Chinese children with ADHD and their parents
香港中文大學公共衛生與初級保健學院的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10